Pharma Executive Consulting Limited in London, WC1H 9BQ

Description

Data updated on: 02-07-2019

Pharma Executive Consulting started conducting its business in 2010 as a Private Limited Company with reg. no. 07426392. The company's registered office was situated in London at Lynton House. The Pharma Executive Consulting Limited business had been operating in this business field for at least 9 years.

The business was managed by a single director: Thomas L. who was controlling it from Wed, 10th Nov 2010 to dissolution date on Tue, 28th May 2019.

Thomas L. was the individual with significant control over this firm, owned over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-11-30	2012-11-30	2013-11-30	2014-11-30	2015-11-30	2016-05-31	2016-11-30	2017-11-30	2018-11-30
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	113 884	121 867	186 786	253 957	53 643	121 233

Balance Sheet
Cash Bank On Hand						173 994	132 423	201 130	100
Current Assets	166 960	157 137	227 112	331 048	408 977	176 428	270 395	308 346	100
Debtors		0	1 022	730	13 079	2 434	137 972	107 216
Net Assets Liabilities						121 233	222 759	348 895	100
Other Debtors						1 978	121 843	105 997
Property Plant Equipment						1 752	1 253
Cash Bank In Hand	166 960	157 137	226 090	330 318	395 898	173 994
Net Assets Liabilities Including Pension Asset Liability	113 884	121 867	186 786	253 957	53 643	121 233
Tangible Fixed Assets	4 443	3 842	3 226	1 128	2 250	1 752

Capital & Reserves
Called Up Share Capital	100	100	100	100	100	100
Profit Loss Account Reserve	113 784	121 767	186 686	253 857	53 543	121 133
Shareholder Funds	113 884	121 867	186 786	253 957	53 643	121 233

Other Financial Data
Total Fixed Assets Additions	5 783	1 126	1 481
Total Fixed Assets Cost Or Valuation	5 783	6 909	8 390	8 390	12 116	12 116
Total Fixed Assets Depreciation	1 340	3 067	5 164	7 262	8 647	9 145
Total Fixed Assets Depreciation Charge In Period	1 340	1 727	2 097	2 098		498
Accumulated Depreciation Impairment Property Plant Equipment						9 145	9 644	10 897	10 897
Average Number Employees During Period						1	1	1	1
Corporation Tax Payable						43 166	49 667	56 171
Creditors						58 166	91 726	103 570
Depreciation Rate Used For Property Plant Equipment							25	25
Fixed Assets	4 443	3 842	3 226	1 128	3 469	2 971	44 090	144 119
Increase From Depreciation Charge For Year Property Plant Equipment							499	1 253
Investments						1 219	42 837	144 119	-144 119
Investments Fixed Assets						1 219	42 837	144 119
Net Current Assets Liabilities	109 441	118 025	183 560	252 829	50 174	118 262	178 669	204 776	100
Other Creditors						7 500	36 634	39 782
Other Investments Other Than Loans						1 219	42 837	144 119	-144 119
Other Taxation Social Security Payable							5 425	7 617
Property Plant Equipment Gross Cost							10 897	10 897	10 897
Total Assets Less Current Liabilities	113 884	121 867	186 786	253 957	53 643	121 233	222 759	348 895	100
Trade Creditors Trade Payables						7 500
Trade Debtors Trade Receivables						456	16 129	1 219
Creditors Due Within One Year Total Current Liabilities	57 519	39 112	43 552	78 219	358 803	58 166
Tangible Fixed Assets Additions	5 783	1 126	1 481		2 507
Tangible Fixed Assets Cost Or Valuation	5 783	6 909	8 390	8 390	10 897	10 897
Tangible Fixed Assets Depreciation	1 340	3 067	5 164	7 262	8 647	9 145
Tangible Fixed Assets Depreciation Charge For Period	1 340	1 727	2 097	2 098		498
Total Fixed Asset Investments Cost Or Valuation					1 219	1 219
Total Investments Fixed Assets					1 219	1 219
Cash Bank				330 318	395 898
Creditors Due Within One Year				78 219	358 803
Number Shares Allotted				100	100
Par Value Share					1
Share Capital Allotted Called Up Paid				-100	-100
Tangible Fixed Assets Depreciation Charged In Period					1 385

Company staff

Thomas L.

Role: Director

Appointed: 10 November 2010

Latest update: 8 January 2024

People with significant control

Thomas L.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	31 August 2020
Account last made up date	30 November 2018
Confirmation statement next due date	31 July 2019
Confirmation statement last made up date	17 July 2018

Annual Accounts 18 August 2016
Start Date For Period Covered By Report	2014-12-01
End Date For Period Covered By Report	30 November 2015
Date Approval Accounts	18 August 2016
Annual Accounts
Start Date For Period Covered By Report	2016-06-01
End Date For Period Covered By Report	30 November 2016
Annual Accounts
Start Date For Period Covered By Report	2016-12-01
End Date For Period Covered By Report	30 November 2017
Annual Accounts
Start Date For Period Covered By Report	2017-12-01
End Date For Period Covered By Report	30 November 2018

Pharma Executive Consulting Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Thomas L.

Graham C.

People with significant control

Thomas L.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies